The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 6, 2008, Pages 473-482

  Nojkov, B ^b   Rubenstein, J H ^b   Adlis, S A ^c   Shaw, M J ^c   Saad, R ^b   Rai, J ^b   Weinman, B ^b   Chey, W D ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c PARK NICOLLET CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; DISTRESS SYNDROME; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REFLUX ESOPHAGITIS; TREATMENT RESPONSE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROTON PUMPS; QUALITY OF LIFE; STRESS;

EID: 39749135114     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03596.x     Document Type: Article

References (40)

1. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001 96: 2905 14.
2. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 1997 112: 1448 56.
3. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997 112: 1798 810.
4. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 100: 190 200.
5. Chey WD, Inadomi JM, Booher A, Sharma VK, Ferdrick AM, Holden CW. Primary care physicians perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol 2005 100: 1243 50.
6. Galmiche JP. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Drugs 2006 66 (Suppl. 1 7 13 Discussion 29-33.
7. Qadeer MA, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006 101: 2646 54.
8. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007 102: 668 85.
9. Martinez SD, Malagon IB, Garewall HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003 17: 537 45.
10. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006 55: 1398 402.
11. Locke GR, Zinsmeister AR, Fett SL, Melton LJ 3rd., Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005 17: 29 34.
12. Lee YC, Wang HP, Chiu HM, et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol 2006 21: 798 804.
13. Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 1995 90: 1797 803.
14. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999 231: 29 37.
15. Avidan B, Sonnenberg A, Giblovich H, Sontag SJ. Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 2001 15: 1907 12.
16. Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 2003 18: 595 604.
17. Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med 2004 66: 426 34.
18. Dean BB, Gano AD, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004 2: 656 64.
19. Carlsson R, Dent J, Watts R, et al. Gastro-esophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroentrol Hepatol 1998 10: 119 24.
20. Johnsson F, Hatlebakk JG, Klintenberg AC, Roman J. Symptom relieving effect of esomeprazole 40 mg daily in patients with heartburn. Scand J Gastroenterol 2003 38: 347 53.
21. Chey WD. Erosive esophagitis and NERD: can we really classify patients with heartburn using endoscopic findings? Clin Gastroenterol Hepatol 2004 2: 654 5.
22. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001 96: 52 7.
23. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998 12: 1067 78.
24. Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther 2001 15: 981 7.
25. Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998 583: 41 9.
26. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983 13: 595 605.
27. Dent J, Brun J, Fendrick AM, et al. An evidence based appraisal of reflux disease management: the Genval Workshop Report. Gut 1999 44 (Suppl. 2 S1 16.
28. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978 2: 653 4.
29. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pinentel M. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci 2006 51: 2113 20.
30. Moayyedi P, Talley NJ. Gastroesophageal reflux disease. Lancet 2006 367: 2086 100.
31. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993 38: 1569 80.
32. Dickman R, Feroze H, Fass R. Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome. Curr Gastroenterol Rep 2006 8: 261 5.
33. Prevalence and treatment of mental health problems. In: Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. [monograph on the Internet] Rockville, MD: Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. SMA 04-3964 2006: [cited 2007 Dec 19]. Available from: http://www.oas. samhsa.gov/NHSDA/2k3NSDUH/2k3results.htm#ch8
34. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999 282: 1737 44.
35. Pogromov AP, Diukova GM, Rykova SM, Bein AM. Psycho-autonomic aspects in patients with gastroesophageal reflux disease, and functional esophageal disorders. Klin Med 2005 83: 41 4.
36. Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004 99: 1152 9.
37. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005 22: 79 94.
38. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995 109: 40 52.
39. Trimble KC, Douglas S, Pryde A, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for generalized disorder of gut sensitivity. Dig Dis Sci 1995 40: 1607 13.
40. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997 32: 974.